Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Bone Loss|Osteoporosis|Breast Cancer
Interventions: DRUG: risedronate
Sponsor: Susan L. Greenspan
Collaborators: University of Pittsburgh